U.S. government bonds and the options volatility index (VIX) are pointing in different directions for the U.S. economy. Both can't be right. Read More
Jim Fink is chief investment strategist for Jim Fink's Options for Income and Velocity Trader. He has traded options for more than 20 years and generated personal profits of more than $5 million. Jim also serves as an investment analyst at Investing Daily’s flagship investing publication, Personal Finance.
Hopelessly overeducated, Jim holds a bachelor's degree from Yale University, a master's degree from Harvard's Kennedy School of Government, a law degree from Columbia University, and an MBA from the University of Virginia's Darden School of Business. For good measure, he has been a member of the Illinois and D.C. bars and is a CFA charterholder.
Prior to joining Investing Daily, and when not incurring student loans hiding out in academe, Jim practiced telecommunications regulatory law for nine years until he realized that he made more money trading stock options than writing briefs. After attending business school, Jim switched gears to the investment realm full-time, working for a university endowment, a private wealth management firm, an insurance and financial planning company, and as a Senior Analyst for an online investment newsletter service that encourages the wearing of funny hats.
A possible but unlikely descendant of legendary brawler and boatman Mike Fink, Jim defies his heritage, believing that investing success requires patience and analysis, not swashbuckling bravado. Besides his passion for analyzing and writing about stocks, Jim likes to hike in the desert Southwest, vacation in Las Vegas, play tennis, and feed his toddler son Cheerios.
If you want to make money investing under Obamacare, think cheap, think basic, think bureaucracy, think . . . Medicaid Nation. Read More
Duke Energy's ouster of Bill Johnson as CEO was the subject of a North Carolina regulatory hearing on Tuesday. Bad publicity could cause the stock to fall further. Read More
If a financial advisor talks more about predictions than process, walk away as fast as you can. Read More
The first new diet pill in 13 years spells hope for millions of obese people. And more diet pill approvals by the FDA are on the horizon. Read More
Why pay full price when you can buy stocks on sale using stock options? Well, there is one reason, but it's not a dealbreaker. Read More